Skip to main content

Genprex, Inc.

GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595248

No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Genprex, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of GNPX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5949−10
Shares5.82M5.89M+71.0K (+1.2%)
Value$19.5M$15.8M−$3.70M (−19.0%)

New holders (8)

Institutions that held Genprex, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to GNPX in Q3 2021
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP409,644$1.10M0.11%
Cypress Capital, LLC100,000$268.0K0.03%
Group One Trading, L.P.98,152$263.0K0.01%
Virtu Financial LLC41,922$112.0K0.01%
HighTower Advisors, LLC26,000$70.0K0.00%
Citadel Advisors LLC25,278$67.0K0.00%
B. Riley Wealth Management, Inc.16,750$45.0K0.00%
Tower Research Capital LLC (TRC)8,981$24.0K0.00%

Sold out (18)

Institutions that held Genprex, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.